Clinical Trial

Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma

Recruiting
View on ClinicalTrials.gov →
Summary
The investigators aim to study the impact of stereotactic radiosurgery, for the treatment of vestibular Schwannoma, on the cochlear, vestibular, gustatory, and facial nerve functions and compare it with a conservatively treated group. The predictive value of radiological tumor characteristics on hearing preservation and vestibular function will be also evaluated. Additionally, the investigators will invite patients with vestibular Schwannoma to fill out questionnaires to assess their quality of life.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-11-30; most recent amendment 2025-01-09.
Trial Details
NCT Number NCT05641441
Lead Sponsor University Hospital, Geneva
Conditions Vestibular Schwannoma, Ototoxicity
Enrollment 258 participants
Start Date 2023-01-24
Primary Completion 2030-11-15 (estimated)
Study Completion 2030-11-15 (estimated)
Updated on ClinicalTrials.gov 2025-01-13